Clinical trial

An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

NCT01598597

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2012-03-01

PhaseN/A

Study timeline

Study start (unknown)2012-03-01Date precision: month

Registry last updated2015-05-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Colorectal Cancerunresolved

Non-Small Cell Lung Cancerunresolved

Glioblastomaunresolved

Renal Cell Cancerunresolved

Interventions

Sponsors & collaborators

Genentech, Inc.lead sponsor

23andMe, Inc.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01598597 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.